Paul M Maciocia (P M Maciocia, Paul Maciocia)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Blood cancer journal

Nature communications

Blood

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Mathieu Ferrari, Matteo Righi, Vania Baldan, Patrycja Wawrzyniecka, Anna Bulek, Alexander Kinna, Biao Ma, Reyisa Bughda, Zulaikha Akbar, Saket Srivastava, Isaac Gannon, Mathew Robson, James E Sillibourne, Ram Jha, Mohamed El-Kholy, Oliver Muhammad Amin, Evangelia Kokalaki, Mohammed Amin Banani, Rehan Hussain, William Day, Wen Chean Lim, Priyanka Ghongane, Jade R Hopkins, Dennis Jungherz, Marco Herling, Martin Welin, Sachin Surade, Michael R Dyson, John McCafferty, Derek Logan, Shaun Cordoba, Simon Thomas, Andrew K Sewell, Paul M Maciocia, Shimobi Onuoha, Martin A Pule
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. Nature communications 15 (1) (2024)
Pedro Horna, Matthew J Weybright, Mathieu Ferrari, Dennis Jungherz, YaYi Peng, Zulaikha Akbar, F Tudor Ilca, Gregory E Otteson, Jansen N Seheult, Janosch Ortmann, Min Shi, Paul M Maciocia, Marco Herling, Martin A Pule, Horatiu Olteanu
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood cancer journal 14 (1) (2024)
Paul M Maciocia, Patrycja A Wawrzyniecka, Nicola C Maciocia, Amy Burley, Thaneswari Karpanasamy, Sam Devereaux, Malika Hoekx, David O'Connor, Theresa Leon, Tanya Rapoz-D'Silva, Rachael Pocock, Sunniyat Rahman, Giuseppe Gritti, Diana C Yánez, Susan Ross, Tessa Crompton, Owen Williams, Lydia Lee, Martin A Pule, Marc R Mansour
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia. Blood 140 (1) (2022)
P A Wawrzyniecka, L Ibrahim, Giuseppe Gritti, Martin A Pule, Paul M Maciocia
Chimeric antigen receptor T cells for gamma-delta T cell malignancies. Leukemia (2021)
Paul M Maciocia, Martin A Pule
Anti-CD1a CAR T cells to selectively target T-ALL. Blood 133 (21) (2019)

Paul M Maciocia.css-eqlu8i{font-size:small;padding-left:4px;} (P M Maciocia, Paul Maciocia)

Publication Activity (10 Years)

Top Topics

Top Venues

Paul M Maciocia (P M Maciocia, Paul Maciocia)